{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T14:10:39Z","timestamp":1794492639486,"version":"4.9.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82404424"],"award-info":[{"award-number":["82404424"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018925","name":"Health Commission of Henan Province","doi-asserted-by":"publisher","award":["LHGJ20230161"],"award-info":[{"award-number":["LHGJ20230161"]}],"id":[{"id":"10.13039\/100018925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016305","name":"The First Affiliated Hospital of Zhengzhou University","doi-asserted-by":"publisher","award":["ZYCXTD202310"],"award-info":[{"award-number":["ZYCXTD202310"]}],"id":[{"id":"10.13039\/501100016305","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ejmech.2025.117649","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T19:23:21Z","timestamp":1744917801000},"page":"117649","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Structure optimization of natural product piperine to obtain novel and potent analogs with anti-inflammation pain and urate-lowering effect"],"prefix":"10.1016","volume":"292","author":[{"given":"Chunxia","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoyang","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengxin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxin","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.117649_bib1","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/s41584-020-0441-1","article-title":"Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors","volume":"16","author":"Dehlin","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.ejmech.2025.117649_bib2","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/S0140-6736(21)00569-9","article-title":"Gout","volume":"397","author":"Dalbeth","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2025.117649_bib3","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1080\/14728222.2023.2247559","article-title":"New drug targets for the treatment of gout arthritis: what's new?","volume":"27","author":"Zaninelli","year":"2023","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.ejmech.2025.117649_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114816","article-title":"Design, synthesis and activity evaluation of novel lesinurad analogues containing thienopyrimidinone or pyridine substructure as human urate transporter 1 inhibitors","volume":"244","author":"Zhang","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117649_bib5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11926-023-01128-3","article-title":"Pipeline therapies for gout","volume":"26","author":"Yip","year":"2023","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.ejmech.2025.117649_bib6","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41584-018-0004-x","article-title":"An update on the genetics of hyperuricaemia and gout","volume":"14","author":"Major","year":"2018","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.ejmech.2025.117649_bib7","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1021\/acs.jmedchem.1c02057","article-title":"Discovery of novel bicyclic Imidazolopyridine-Containing human urate transporter 1 inhibitors as hypouricemic drug candidates with improved efficacy and favorable druggability","volume":"65","author":"Zhao","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117649_bib8","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1002\/ptr.7099","article-title":"Natural products: a lead for drug discovery and development","volume":"35","author":"Chopra","year":"2021","journal-title":"Phytother Res."},{"key":"10.1016\/j.ejmech.2025.117649_bib9","doi-asserted-by":"crossref","first-page":"4540","DOI":"10.1021\/acs.jmedchem.4c02591","article-title":"Structure optimization of natural product catalpol to obtain novel and potent analogs against heart failure","volume":"68","author":"Liu","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117649_bib10","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/ptr.6855","article-title":"Piperine: a review of its biological effects","volume":"35","author":"Haq","year":"2020","journal-title":"Phytother Res."},{"key":"10.1016\/j.ejmech.2025.117649_bib11","doi-asserted-by":"crossref","first-page":"19581","DOI":"10.1021\/acs.jafc.3c06683","article-title":"Piperine attenuates Bmal1-Mediated glucose metabolism disorder in a Trpv1-Dependent manner in HepG2 cells","volume":"71","author":"Sun","year":"2023","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ejmech.2025.117649_bib12","article-title":"The role of Piper chaba hunt. And its pure compound, piperine, on TRPV1 activation and adjuvant effect","volume":"20","author":"Panthong","year":"2020","journal-title":"BMC Compl. Med. Ther."},{"key":"10.1016\/j.ejmech.2025.117649_bib13","doi-asserted-by":"crossref","first-page":"288","DOI":"10.14202\/vetworld.2022.288-298","article-title":"Immunosuppression by piperine as a regulator of the NLRP3 inflammasome through MAPK\/NF-\u03baB in monosodium urate-induced rat gouty arthritis","volume":"15","author":"Jati","year":"2022","journal-title":"Vet. World"},{"key":"10.1016\/j.ejmech.2025.117649_bib14","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/s41590-021-00886-5","article-title":"NLRP3 inflammasome in cancer and metabolic diseases","volume":"22","author":"Sharma","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ejmech.2025.117649_bib15","doi-asserted-by":"crossref","first-page":"14447","DOI":"10.1021\/acs.jmedchem.3c01370","article-title":"Recent progress and prospects of small molecules for NLRP3 inflammasome inhibition","volume":"66","author":"Li","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117649_bib16","doi-asserted-by":"crossref","first-page":"6565","DOI":"10.1021\/acs.jafc.3c07655","article-title":"Piperine improves hyperuricemic nephropathy by inhibiting URAT1\/GLUT9 and the AKT-mTOR pathway","volume":"72","author":"Li","year":"2024","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ejmech.2025.117649_bib17","doi-asserted-by":"crossref","first-page":"14668","DOI":"10.1021\/acs.jmedchem.4c01480","article-title":"Discovery of a potent and orally bioavailable xanthine oxidase\/urate transporter 1 dual inhibitor as a potential treatment for hyperuricemia and gout","volume":"67","author":"Yang","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117649_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114890","article-title":"Recent advances in gout drugs","volume":"245","author":"Shi","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117649_bib19","doi-asserted-by":"crossref","first-page":"10829","DOI":"10.1021\/acs.jmedchem.0c00223","article-title":"Novel human urate transporter 1 inhibitors as hypouricemic drug candidates with favorable druggability","volume":"63","author":"Zhao","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117649_bib20","doi-asserted-by":"crossref","first-page":"5032","DOI":"10.1021\/acs.jmedchem.4c00136","article-title":"Discovery of a novel thienopyrimidine compound as a urate transporter 1 and glucose transporter 9 dual inhibitor with improved efficacy and favorable druggability","volume":"67","author":"Shi","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117649_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2024.117750","article-title":"Discovery of first-in-class highly selective TRPV1 antagonists with dual analgesic and hypoglycemic effects","volume":"107","author":"Liu","year":"2024","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117649_bib22","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/s41422-024-01023-1","article-title":"Transport mechanism and structural pharmacology of human urate transporter URAT1","volume":"34","author":"Dai","year":"2024","journal-title":"Cell Res."},{"key":"10.1016\/j.ejmech.2025.117649_bib23","doi-asserted-by":"crossref","first-page":"11658","DOI":"10.1021\/acs.jmedchem.2c00469","article-title":"Discovery of potent and selective transient receptor potential vanilloid 1 (TRPV1) agonists with analgesic effects in vivo based on the functional conversion induced by altering the orientation of the indazole core","volume":"65","author":"Liang","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117649_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2019.113678","article-title":"Pharmacological inhibition of TRPM8-induced gene transcription","volume":"170","author":"Thiel","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117649_bib25","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1515\/sjpain-2018-0103","article-title":"Effect of the market withdrawal of dextropropoxyphene on use of other prescribed analgesics","volume":"18","author":"Reset","year":"2018","journal-title":"Scand. J. Pain"},{"key":"10.1016\/j.ejmech.2025.117649_bib26","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/FJC.0b013e31818eec8d","article-title":"Rainer netzer, and clemens m\u00f6ller, effects of common antitussive drugs on the hERG potassium channel current","volume":"52","author":"Heike Deisemann","year":"2008","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117649_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112290","article-title":"hERG toxicity assessment: useful guidelines for drug design","volume":"195","author":"Garrido","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117649_bib28","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/d41573-021-00197-2","article-title":"Navigating a new path to Nav1.7 for pain","volume":"21","author":"Kingwell","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2025.117649_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114947","article-title":"Design, synthesis, and evaluation of tricyclic compounds containing phenyl-tetrazole as XOR inhibitors","volume":"246","author":"Peng","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117649_bib30","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1080\/03602532.2021.1970178","article-title":"Drug metabolic stability in early drug discovery to develop potential lead compounds","volume":"53","author":"Gajula","year":"2021","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.ejmech.2025.117649_bib31","doi-asserted-by":"crossref","first-page":"6743","DOI":"10.1021\/acs.jmedchem.3c00101","article-title":"Rationally engineered CYP3A4 fluorogenic substrates for functional imaging analysis and drug\u2013drug interaction studies","volume":"66","author":"He","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117649_bib32","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/bdd.1813","article-title":"Identification of CYP isozymes involved in benzbromarone metabolism in human liver microsomes","volume":"33","author":"Kobayashi","year":"2012","journal-title":"Biopharm Drug Dispos."},{"key":"10.1016\/j.ejmech.2025.117649_bib33","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.tox.2014.08.002","article-title":"Hepatocellular toxicity of benzbromarone: effects on mitochondrial function and structure","volume":"324","author":"Felser","year":"2014","journal-title":"Toxicology"},{"key":"10.1016\/j.ejmech.2025.117649_bib34","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/nrd.2018.97","article-title":"Targeting the NLRP3 inflammasome in inflammatory diseases","volume":"17","author":"Mangan","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2025.117649_bib35","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/s41419-020-2673-z","article-title":"Delayed treatment with an autophagy inhibitor 3-MA alleviates the progression of hyperuricemic nephropathy","volume":"11","author":"Shi","year":"2020","journal-title":"Cell Death Dis."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425004143?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425004143?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T14:07:35Z","timestamp":1762265255000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425004143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":35,"alternative-id":["S0223523425004143"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117649","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure optimization of natural product piperine to obtain novel and potent analogs with anti-inflammation pain and urate-lowering effect","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117649","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117649"}}